Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022. From Wikipedia
The acquisition includes VG-3927, a Phase 2-ready TREM2 agonist, with a focus on microglial neuroprotection in Alzheimer’s disease.
